Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD0780 in Healthy Adults With Elevated LDL-C Levels
NCT07423598Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in hypercholesterolemia comparing AZD0780 with Placebo (2 arms). Primary endpoint: Low-Density Lipoprotein Cholesterol at 4 weeks. Started Feb 2026; status: completed.
02
Drugs
laroprovstat
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT07423598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07423598.